Literature DB >> 10207340

Method of physician remuneration and rates of antibiotic prescription.

J M Hutchinson1, R N Foley.   

Abstract

BACKGROUND: Rates of antibiotic prescription in Canada far exceed generally accepted rates of bacterial infection, which led the authors to postulate that rates of antibiotic prescription depend to some extent on factors unrelated to medical indication. The associations between antibiotic prescription rates and physician characteristics, in particular, method of remuneration and patient volume, were explored.
METHODS: The authors evaluated all 153,047 antibiotic prescriptions generated by 476 Newfoundland general practitioners and paid for by the Newfoundland Drug Plan over the 1-year period ending Aug. 31 1996, and calculated rates of antibiotic prescription. Linear and logistic regression models controlling for several physician characteristics, specifically age, place of education (Canada or elsewhere), location of practice (urban or rural) and proportion of elderly patients seen, were used to analyse rates of antibiotic prescription.
RESULTS: Fee-for-service payment (rather than salary) and greater volume of patients were strongly associated with higher antibiotic prescription rates. Fee-for-service physicians were much more likely than their salaried counterparts to prescribe at rates above the median value of 1.51 antibiotic prescriptions per unique patient per year. The association between rate of antibiotic prescription and patient volume (as measured by number of unique patients prescribed to) was evident for all physicians. However, the association was much stronger for fee-for-service physicians. Physicians with higher patient volumes prescribed antibiotics at higher rates.
INTERPRETATION: In this study factors other than medical indication, in particular method of physician remuneration and patient volume, played a major role in determining antibiotic prescribing practices.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207340      PMCID: PMC1230193     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  12 in total

1.  How does Canada do it? A comparison of expenditures for physicians' services in the United States and Canada.

Authors:  V R Fuchs; J S Hahn
Journal:  N Engl J Med       Date:  1990-09-27       Impact factor: 91.245

2.  Resistance to erythromycin in group A streptococci.

Authors:  H Seppälä; A Nissinen; H Järvinen; S Huovinen; T Henriksson; E Herva; S E Holm; M Jahkola; M L Katila; T Klaukka
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

3.  Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.

Authors:  R Gonzales; J F Steiner; M A Sande
Journal:  JAMA       Date:  1997-09-17       Impact factor: 56.272

4.  Rhinovirus infections in an industrial population. I. The occurrence of illness.

Authors:  J M Gwaltney; J O Hendley; G Simon; W S Jordan
Journal:  N Engl J Med       Date:  1966-12-08       Impact factor: 91.245

5.  Antibiotic-resistant Staphylococcus aureus and hospital antibiotic policies.

Authors:  M Ridley; R Lynn; D Barrie; K C Stead
Journal:  Lancet       Date:  1970-01-31       Impact factor: 79.321

Review 6.  Antimicrobial resistance in hospital organisms and its relation to antibiotic use.

Authors:  J E McGowan
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

7.  Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study.

Authors:  D W Teele; J O Klein; B Rosner
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

8.  Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial.

Authors:  I Koivula; M Stén; M Leinonen; P H Mäkelä
Journal:  Am J Med       Date:  1997-10       Impact factor: 4.965

Review 9.  Pneumonia in the elderly.

Authors:  T J Marrie
Journal:  Curr Opin Pulm Med       Date:  1996-05       Impact factor: 3.155

10.  Relation between physician characteristics and prescribing for elderly people in New Brunswick.

Authors:  W Davidson; D W Molloy; G Somers; M Bédard
Journal:  CMAJ       Date:  1994-03-15       Impact factor: 8.262

View more
  19 in total

Review 1.  Antimicrobial prescribing.

Authors:  M B Prentice
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

2.  Can the health care system buy better antibiotic prescribing behaviour?

Authors:  M A Levine; A Pradhan
Journal:  CMAJ       Date:  1999-04-06       Impact factor: 8.262

3.  Listening for prescriptions: a national consultation on pharmaceutical policy issues.

Authors:  Steve Morgan; Colleen M Cunningham
Journal:  Healthc Policy       Date:  2010-11

4.  Antibiotic resistance in Canada at the dawn of the new millennium - a model for the developed world?

Authors:  J M Conly; B L Johnston
Journal:  Can J Infect Dis       Date:  2000-09

5.  Revenge of the killer microbe.

Authors:  Sandra R Arnold
Journal:  CMAJ       Date:  2007-10-09       Impact factor: 8.262

Review 6.  Antimicrobial resistance in Canada.

Authors:  John Conly
Journal:  CMAJ       Date:  2002-10-15       Impact factor: 8.262

7.  Influence of patient payment on antibiotic prescribing in Irish general practice: a cohort study.

Authors:  Marion Murphy; Stephen Byrne; Colin P Bradley
Journal:  Br J Gen Pract       Date:  2011-09       Impact factor: 5.386

8.  Role of diagnostic labeling in antibiotic prescription.

Authors:  J M Hutchinson; S Jelinski; D Hefferton; G Desaulniers; P S Parfrey
Journal:  Can Fam Physician       Date:  2001-06       Impact factor: 3.275

9.  One hundred earaches. Family practice case series.

Authors:  G Worrall
Journal:  Can Fam Physician       Date:  2000-05       Impact factor: 3.275

10.  Antibiotic availability and the prevalence of pediatric pneumonia during a physicians' strike.

Authors:  Ken Crocker; Benvon Cramer; James M Hutchinson
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-05       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.